RXRX · Recursion Pharmaceuticals, Inc. · Share Buybacks
$2.49
-0.23 (-8.46%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$1.53B
Shares
622.76M
Volume · Nov 20
29.66M
Avg daily vol (3M)
24.44M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Key facts
CIK
1601830
CUSIP
75629V104
13F (30d)
381 filings
327 filers
Visit website
Investor relations